{"version":"1.0","type":"link","title":"The European medicines agency review of belzutifan (Welireg) for the treatment of adult patients with von Hippel-Lindau disease-associated tumors.","author_name":"Baron A 외","author_url":"https://prs-insight.online/author/Baron%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/87345","thumbnail_width":1200,"thumbnail_height":630}